Preganglionic autonomic neurons are the efferent neurons of the autonomic nervous system (ANS) that originate in the central nervous system and project to autonomic ganglia, where they synapse with postganglionic neurons. These neurons are the critical intermediaries between the CNS and peripheral effector organs, controlling involuntary functions including heart rate, blood pressure, digestion, pupillary response, and glandular secretion[^1].
The autonomic nervous system is divided into three major subdivisions:
- Sympathetic (thoracolumbar): Fight-or-flight responses
- Parasympathetic (craniosacral): Rest-and-digest functions
- Enteric: Gastrointestinal regulation
Preganglionic neurons are the common efferent pathway for all three divisions, serving as the final CNS output to autonomic effectors. They are primarily cholinergic, releasing acetylcholine (ACh) at their synapses in autonomic ganglia[^2].
Located in the intermediolateral cell column of the spinal cord:
- Distribution: T1-L2 (thoracolumbar outflow)
- Axon length: Generally short (synapse in paravertebral or prevertebral ganglia)
- Target ganglia:
- Paravertebral (chain ganglia)
- Prevertebral (collateral) ganglia (celiac, superior mesenteric, inferior mesenteric)
Located in specific brainstem nuclei and sacral spinal cord:
- Cranial nerves: III (oculomotor), VII (facial), IX (glossopharyngeal), X (vagus)
- Sacral outflow: S2-S4
- Axon length: Generally long (ganglia located near or within target organs)
- Target ganglia: Terminal ganglia in or near effector organs
- Primary neurotransmitter: Acetylcholine
- Receptor type: Nicotinic ACh receptors (nAChRs)
- Co-transmitters: Some populations release neuropeptides (e.g., CGRP, substance P)
- Cardiac acceleration: Increased heart rate and contractility
- Vasoconstriction: Blood pressure regulation
- Pupillary dilation: Mydriasis
- Thermoregulation: Sweating and cutaneous vasoconstriction
- Metabolic effects: Glycogenolysis, lipolysis
- Cardiac deceleration: Decreased heart rate
- Bronchoconstriction: Reduced airway diameter
- Pupillary constriction: Miosis
- Digestive motility: GI tract peristalsis
- Glandular secretion: Salivary, digestive, lacrimal
- GI motility: Peristalsis and segmentation
- Secretion: Digestive enzymes and mucus
- Blood flow: Local regulation
Autonomic dysfunction is a common and often early feature of PD:
- Sympathetic denervation: Reduced norepinephrine levels
- Orthostatic hypotension: Impaired baroreflex
- Gastrointestinal dysmotility: Vagal degeneration
- Urinary dysfunction: Detrusor overactivity
- Cardiac metaiodobenzylguanidine (MIBG) uptake: Reduced in PD[^3]
Severe autonomic failure is a hallmark of MSA:
- Early autonomic failure: Orthostatic hypotension, urinary dysfunction
- Neurodegeneration: Preganglionic sympathetic neurons affected
- Lewy pathology: May involve autonomic regions
- Parkinsonian (MSA-P) vs cerebellar (MSA-C) subtypes[^4]
- Selective degeneration: Autonomic neurons only
- Orthostatic hypotension: Profound
- No CNS involvement: Initially
- Lewy body pathology: May develop over time
- Autonomic dysfunction: Less prominent than in PD/MSA
- Baroreflex impairment: Associated with disease progression
- Cardiac sympathetic changes: Variable findings[^5]
- Autonomic involvement: Less common
- Bulbar dysfunction: Affects parasympathetic output
- Respiratory control: Autonomic neurons affected in advanced disease
- Cholinergic agonists: Direct and indirect acting
- Anticholinergics: Blocking excess parasympathetic tone
- Sympathomimetics: α and β-adrenergic agents
- ACE inhibitors: Modulating autonomic tone
- Autonomic effects: DBS can affect autonomic function
- Target selection: Autonomic outcomes considered
- Heart rate variability: Autonomic function marker
- Skin conductance: Sympathetic function
- Baroreflex sensitivity: Blood pressure regulation
The study of Preganglionic Autonomic Neurons has evolved significantly over the past decades. Research in this area has revealed important insights into the underlying mechanisms of neurodegeneration and continues to drive therapeutic development.
Historical context and key discoveries in this field have shaped our current understanding and will continue to guide future research directions.
- Janig W, et al. (2008) - Integrative action of the autonomic nervous system
- Low PA, et al. (2013) - Clinical autonomic disorders
- Jain S, et al. (2012) - Autonomic dysfunction in Parkinson's disease
- Kollensperger M, et al. (2010) - Progression of autonomic dysfunction in multiple system atrophy
- Aggarwal S, et al. (2013) - Autonomic dysfunction in Alzheimer's disease